2 results
Approved WMOCompleted
to determine the normal FGF23 response in case of hypophosphatemia
Approved WMOCompleted
To determine if short-term treatment with the selective beta-2-adrenergic agonist clenbuterol improves glucose disposal via the mTORC2 pathway in lean, healthy male individuals with normal physical activity